Probiotic Prophylaxis in Adult Women with Recurrent Uncomplicated Urinary Tract Infections: A Systematic Review of Randomized Controlled Trials
Abstract
INTRODUCTION
Recurrent urinary tract infection (rUTI) in women represents a common clinical problem whose traditional management through continuous antibiotic prophylaxis contributes to the development of antimicrobial resistance. Probiotics, particularly Lactobacillus strains, have emerged as a potentially effective non-antibiotic alternative by restoring the urogenital microbiota.
METHODS
A systematic review was conducted following PRISMA guidelines. Randomized controlled trials evaluating the efficacy and safety of probiotic prophylaxis, administered orally or intravaginally, in adult women with rUTI, compared to placebo or antibiotic prophylaxis, were included. MEDLINE, EMBASE, CENTRAL, LILACS, and Google Scholar were searched up to December 2025. Risk of bias was assessed using RoB 2, and the certainty of evidence with GRADE. Due to clinical heterogeneity, a narrative synthesis was performed.
RESULTS
Four randomized controlled trials (n=616) were included. Compared with placebo, probiotics were associated with a reduction in the recurrence of urinary tract infections and an increase in the time to first recurrence. The most precise effect estimate available was a relative risk of 0.50 (95% CI: 0.20-1.20) for intravaginal Lactobacillus crispatus, with a recurrence rate of 15% versus 27% in the placebo group. Intravaginal administration showed a consistent trend toward greater clinical benefit across all studies, associated with effective vaginal recolonization. No…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 616 participants or records.
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.